期刊
TRENDS IN NEUROSCIENCES
卷 41, 期 7, 页码 442-456出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tins.2018.03.011
关键词
-
资金
- Simons Foundation (SFARI) [402281, 513133, 491201, 349984]
- NIH (NIMH) [100047]
- Stanley Center for Psychiatric Research at the Broad Institute
Advances in gene discovery for neurodevelopmental disorders have identified SCN2A dysfunction as a leading cause of infantile seizures, autism spectrum disorder, and intellectual disability. SCN2A encodes the neuronal sodium channel Na(V)1.2. Functional assays demonstrate strong correlation between genotype and phenotype. This insight can help guide therapeutic decisions and raises the possibility that ligands that selectively enhance or diminish channel function may improve symptoms. The well-defined function of sodium channels makes SCN2A an important test case for investigating the neurobiology of neurodevelopmental disorders more generally. Here, we discuss the progress made, through the concerted efforts of a diverse group of academic and industry scientists as well as policy advocates, in understanding and treating SCN2A-related disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据